Clinical Trials Logo
  1. Home
  2. Urologic Diseases
  3. NCT04763538
  4. Details
NCT04763538 Clinical Trial

Quality and Outcome Measurements of Urological Patients

Urologic Diseases Clinical Trial

Official title:
Quality and Outcome Measurements of Urological Patients

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT04763538
Other study ID # ID 2020-02852
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 1, 2021
Est. completion date April 30, 2028

Study information
Verified date March 2023
Source University Hospital Inselspital, Berne
Contact Roland Seiler, Prof.
Phone +41316321349
Email Roland.Seiler@insel.ch
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Prospectively, all available parameters of urologic patients treated at the study sites will be acquired and stored in multilayered databases. Upon a given samples size, neuronal networks will be trained to define clinical endpoints. Beside uro-oncological patients also patients with other urological diseases will be enrolled.

Recruitment information / eligibility
Status Recruiting
Enrollment 2000
Est. completion date April 30, 2028
Est. primary completion date April 30, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - All patients treated at the study sites, signed informed consent Exclusion Criteria: - No consent to record medical history

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Standard of care
Patients are treated according to the standard of care for each individual disease.

Locations
Country Name City State
Switzerland Department of Urology, Hospital Center Biel Biel
Switzerland Roland Seiler Biel

Sponsors (2)
Lead Sponsor Collaborator
University Hospital Inselspital, Berne Hospital Centre Biel/Bienne

Country where clinical trial is conducted

Switzerland, 

Outcome
Type Measure Description Time frame Safety issue
Primary Disease specific primary endpoint Neuronal networks will be trained to define the respective endpoints for the diseases 4-5 years
See also
  Status Clinical Trial Phase
Recruiting NCT06397287 - PROM Project Urology
Completed NCT03572348 - VeSpAR: Comparing Vessel-Sparing Anastomotic Repair and Transecting Anastomotic Repair in Isolated Short Bulbar Strictures. N/A
Completed NCT03339609 - Uroflow Measurement With Electromyography (EMG) to Identify Lower Urinary Tract Symptoms (LUTS): Conducted on Healthy Children N/A
Active, not recruiting NCT01529658 - Renal Hypothermia During Partial Nephrectomy N/A
Completed NCT05082142 - Tranexamic Acid to Improve Same-day Discharge Rates After Holmium Laser Enucleation of the Prostate (HoLEP) Phase 4
Completed NCT03668262 - ED50 of Cis-atracurium for Laryngeal Mask Incubation in General Anesthesia
Not yet recruiting NCT03899298 - Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions Phase 1
Completed NCT05032287 - Medical Expulsive Therapy Post-SWL For Renal Stones N/A
Active, not recruiting NCT03243682 - The Alternating Bidirectional Versus The Standard Approach During Shock Wave Lithotripsy For Renal And Upper Lumbar Ureteric Stones N/A
Recruiting NCT05169892 - Aquablation in Benign Prostatic Hyperplasia in Canada
Enrolling by invitation NCT03234543 - Remote Ischemic Conditioning in Abdominal Surgery N/A
Recruiting NCT05201131 - Canadian Cohort of Convective Thermal Therapy Using Rezūm System in Benign Prostatic Hyperplasia (BPH).
Recruiting NCT06187870 - Bank of Biological Material From Patients and Healthy Donors for the Study of Urological and Uro-oncological Pathologies
Completed NCT03847909 - A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2 Phase 2
Recruiting NCT04972890 - The Outcomes of Intracavernosal Umbilical Cord Mesenchymal Stem Cells Implantation in Patients With Diabetic Erectile Dysfunction Phase 2/Phase 3
Not yet recruiting NCT03258658 - Safety and Feasibility Study of Autologous Engineered Urethral Constructs for the Treatment of Strictures Phase 1
Terminated NCT02543645 - A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer Phase 1
Terminated NCT03843073 - Connected Catheter- Safety and Effectiveness Study N/A
Terminated NCT04826484 - Opioid Reduction Initiative During Outpatient Pediatric Urologic Procedures Using Exparel Phase 3
Terminated NCT04059159 - Connected Catheter - Safety and Effectiveness Study N/A